Tissue Repair Ltd (AU:TRP) has released an update.
Tissue Repair Ltd is making strides in the treatment of chronic and acute wounds with its product Glucoprime®. The company is progressing through various clinical phases and aims to launch TR Pro+ following TGA approval. Investors are keenly watching these developments, anticipating potential impacts on the stock market.
For further insights into AU:TRP stock, check out TipRanks’ Stock Analysis page.